טוען...
Effectiveness of a novel cellular therapy to treat multidrug-resistant tuberculosis
INTRODUCTION: We urgently need novel treatments for multidrug-resistant tuberculosis (MDR-TB). Autologous mesenchymal stromal cell (MSC) infusion is one such possibility due to its potential to repair damaged lung tissue and boost immune responses. We aimed to assess the effectiveness of MSC to impr...
שמור ב:
| הוצא לאור ב: | J Clin Tuberc Other Mycobact Dis |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4894747/ https://ncbi.nlm.nih.gov/pubmed/27284577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jctube.2016.05.003 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|